434 followers
RT @FrontNeurol: New Research: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Coh…
RT @FrontNeurol: New Research: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Coh…
RT @FrontNeurol: New Research: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Coh…
New Research: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE: Introduction The Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA… https://t.co/l